MedTrace Logo

Outpatient Percutaneous Coronary Intervention

NCT00419055 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2012-04-02

No results posted yet for this study

Summary

To determine the safety and feasibility of same day discharge after elective coronary percutaneous intervention in a selected stable patient population. The hypothesis to be tested is that in an appropriately selected stable coronary artery disease population post percutaneous coronary intervention, early discharge is safe and feasible.

Conditions

Interventions

PROCEDURE

Early discharge after percutaneous coronary intervenntion

Eligible patients receive Bivalirudin at the standard dose during PCI and all have to be eligible for femoral access seal.

Sponsors & Collaborators

Principal Investigators

  • Howard C Herrmann, M.D. · University of Pennsylvania

  • Ruchira Glaser, M.D. · University of Pennsylvania

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Completion
2006-08-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00419055 on ClinicalTrials.gov